Impact of issuing longer- versus shorter-duration prescriptions: a systematic review

King S, Miani C, Exley J, Larkin J, Kirtley A, Payne RA (2018)
BRITISH JOURNAL OF GENERAL PRACTICE 68(669): E286-E292.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ;
Abstract / Bemerkung
Background Long-term conditions place a substantial burden on primary care services, with drug therapy being a core aspect of clinical management. However, the ideal frequency for issuing repeat prescriptions for these medications is unknown. Aim To examine the impact of longer-duration (2-4 months) versus shorter-duration (28-day) prescriptions. Design and setting Systematic review of primary care studies. Method Scientific and grey literature databases were searched from inception until 21 October 2015. Eligible studies were randomised controlled trials and observational studies that examined longer prescriptions (2-4 months) compared with shorter prescriptions (28 days) in patients with stable, chronic conditions being treated in primary care. Outcomes of interest were: health outcomes, adverse events, medication adherence, medication wastage, professional administration time, pharmacists' time and/or costs, patient experience, and patient out-of-pocket costs. Results From a search total of 24 876 records across all databases, 13 studies were eligible for review. Evidence of moderate quality from nine studies suggested that longer prescriptions are associated with increased medication adherence. Evidence from six studies suggested that longer prescriptions may increase medication waste, but results were not always statistically significant and were of very low quality. No eligible studies were identified that measured any of the other outcomes of interest, including health outcomes and adverse events. Conclusion There is insufficient evidence relating to the overall impact of differing prescription lengths on clinical and health service outcomes, although studies do suggest medication adherence may improve with longer prescriptions. UK recommendations to provide shorter prescriptions are not substantiated by the current evidence base.
Erscheinungsjahr
Zeitschriftentitel
BRITISH JOURNAL OF GENERAL PRACTICE
Band
68
Ausgabe
669
Seite(n)
E286-E292
ISSN
eISSN
PUB-ID

Zitieren

King S, Miani C, Exley J, Larkin J, Kirtley A, Payne RA. Impact of issuing longer- versus shorter-duration prescriptions: a systematic review. BRITISH JOURNAL OF GENERAL PRACTICE. 2018;68(669):E286-E292.
King, S., Miani, C., Exley, J., Larkin, J., Kirtley, A., & Payne, R. A. (2018). Impact of issuing longer- versus shorter-duration prescriptions: a systematic review. BRITISH JOURNAL OF GENERAL PRACTICE, 68(669), E286-E292. doi:10.3399/bjgp18X695501
King, S., Miani, C., Exley, J., Larkin, J., Kirtley, A., and Payne, R. A. (2018). Impact of issuing longer- versus shorter-duration prescriptions: a systematic review. BRITISH JOURNAL OF GENERAL PRACTICE 68, E286-E292.
King, S., et al., 2018. Impact of issuing longer- versus shorter-duration prescriptions: a systematic review. BRITISH JOURNAL OF GENERAL PRACTICE, 68(669), p E286-E292.
S. King, et al., “Impact of issuing longer- versus shorter-duration prescriptions: a systematic review”, BRITISH JOURNAL OF GENERAL PRACTICE, vol. 68, 2018, pp. E286-E292.
King, S., Miani, C., Exley, J., Larkin, J., Kirtley, A., Payne, R.A.: Impact of issuing longer- versus shorter-duration prescriptions: a systematic review. BRITISH JOURNAL OF GENERAL PRACTICE. 68, E286-E292 (2018).
King, Sarah, Miani, Céline, Exley, Josephine, Larkin, Jody, Kirtley, Anne, and Payne, Rupert A. “Impact of issuing longer- versus shorter-duration prescriptions: a systematic review”. BRITISH JOURNAL OF GENERAL PRACTICE 68.669 (2018): E286-E292.

1 Zitation in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

45 References

Daten bereitgestellt von Europe PubMed Central.


Baird B, Charles A, Honeyman M., 2016

AUTHOR UNKNOWN, 2007

AUTHOR UNKNOWN, 2007

AUTHOR UNKNOWN, 2009

AUTHOR UNKNOWN, 2011

AUTHOR UNKNOWN, 2013
A day to day analysis of the unwanted medicinal products returned to community pharmacies for disposal.
Hawksworth GM, Wright DJ, Chrystyn H., 1996

AUTHOR UNKNOWN, 2013
Unplanned medication discontinuation as a potential pharmacovigilance signal: a nested young person cohort study.
Sun AP, Kirby B, Black C., 2014
UK interventions to control medicines wastage: a critical review.
White KG., Int J Pharm Pract 18(3), 2010
PMID: 20509346
Restricting patients' medication supply to one month: saving or wasting money?
Domino ME, Olinick J, Sleath B, Leinwand S, Byrns PJ, Carey T., Am J Health Syst Pharm 61(13), 2004
PMID: 15287233
Duration of initial antihypertensive prescription and medication adherence: a cohort study among 203,259 newly diagnosed hypertensive patients.
Wong MC, Tam WW, Wang HH, Cheung CS, Tong EL, Cheung NT, Leeder SR, Griffiths SM., Int. J. Cardiol. 182(), 2014
PMID: 25638445
Trends in thyroid hormone prescribing and consumption in the UK.
Mitchell AL, Hickey B, Hickey JL, Pearce SH., BMC Public Health 9(), 2009
PMID: 19432950

AUTHOR UNKNOWN, 2009
The drivers of overspending on prescription drugs in Quebec.
Smolina K, Morgan S., Healthc Policy 10(2), 2014
PMID: 25617512
Long term costs and health consequences of issuing shorter duration prescriptions for patients with chronic health conditions in the English NHS.
Martin A, Payne R, Wilson ECF., 2018

AUTHOR UNKNOWN, 2017
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D., Ann. Intern. Med. 151(4), 2009
PMID: 19622512

AUTHOR UNKNOWN, 2018
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP., BMJ 355(), 2016
PMID: 27733354
GRADE guidelines: 3. Rating the quality of evidence.
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH., J Clin Epidemiol 64(4), 2011
PMID: 21208779
A retrospective comparative analysis of medication waste from day supply plan design in specialty pharmacy
Faris RJ, Filipek TM, Tang J., 2010
Adherence to chronic medication therapy associated with 90-day supplies compared with 30-day supplies
Hermes M, Gleason PP, Starner CI., 2010
Comparing medication adherence and wastage among three different retail programs
Jiang JZ, Khandelwal NG, Lee KY., 2007
Wasted medication: how big is the problem?
Ryvkin M, Garavaglia S., 2009
Impact of prescription size on statin adherence and cholesterol levels.
Batal HA, Krantz MJ, Dale RA, Mehler PS, Steiner JF., BMC Health Serv Res 7(), 2007
PMID: 17961256
Comparing medication wastage by fill quantity and fulfillment channel
Murphy P, Kahndelwal N, Duncan I., 2012
Trends in antidepressant prescribing for new episodes of depression and implications for health system quality measures.
Pfeiffer PN, Szymanski BR, Valenstein M, McCarthy JF, Zivin K., Med Care 50(1), 2012
PMID: 22182925
The effect of prescription size on acquisition of maintenance medications.
Steiner JF, Robbins LJ, Roth SC, Hammond WS., J Gen Intern Med 8(6), 1993
PMID: 8320574
Medication days’ supply, adherence, wastage, and cost among chronic patients in Medicaid
Taitel M, Fensterheim L, Kirkham H., 2012
Predictors of medication-refill adherence in an indigent rural population.
Schectman JM, Bovbjerg VE, Voss JD., Med Care 40(12), 2002
PMID: 12458310
Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system.
Schmittdiel JA, Nichols GA, Dyer W, Steiner JF, Karter AJ, Raebel MA., Med Care 53(4), 2015
PMID: 25719517
A model for comparing unnecessary costs associated with various prescription fill-quantity policies: illustration using VA data
Walton SM, Arondekar BV, Johnson NE, Schumock GT., 2001
Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment.
Domino ME, Martin BC, Wiley-Exley E, Richards S, Henson A, Carey TS, Sleath B., Health Serv Res 46(3), 2011
PMID: 21306363
Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication.
Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL., Ann Pharmacother 43(1), 2009
PMID: 19126828
Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting.
Dragomir A, Cote R, White M, Lalonde L, Blais L, Berard A, Perreault S., Value Health 13(1), 2009
PMID: 19695008
Effect of statin adherence on cerebrovascular disease in primary prevention.
Perreault S, Ellia L, Dragomir A, Cote R, Blais L, Berard A, Lalonde L., Am. J. Med. 122(7), 2009
PMID: 19559167
Assessing compliance to antihypertensive medications using computer-based pharmacy records.
Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP., Med Care 35(11), 1997
PMID: 9366895
Medication Adherence Measures: An Overview.
Lam WY, Fresco P., Biomed Res Int 2015(), 2015
PMID: 26539470
Understanding can lead to a solution for non-adherence
Payne R., 2014
Cost savings associated with filling a 3-month supply of prescription medicines.
Rabbani A, Alexander GC., Appl Health Econ Health Policy 7(4), 2009
PMID: 19905039

AUTHOR UNKNOWN, 2009

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 29530921
PubMed | Europe PMC

Suchen in

Google Scholar